National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

HARDBACK
price:$69.95
add to cart

Rights & Permissions

topleft topright

From Cancer Patient to Cancer Survivor: Lost in Transition (2005)
National Cancer Policy Board (NCPB)

Citation Manager

. "3 The Medical and Psychological Concerns of Cancer Survivors After Treatment." From Cancer Patient to Cancer Survivor: Lost in Transition. Washington, DC: The National Academies Press, 2005.

Please select a format:

BibTeX EndNote RefMan


Page
159
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


From Cancer Patient to Cancer Survivor: Lost in Transition

Recommended preventive behaviors, interventions, or genetic testing:

This patient already has a very health lifestyle and habits, but she is encouraged to avoid weight gain and to remain physically active. Genetic testing has been advised as noted earlier. Patient given NCI booklet, Life After Cancer Treatment, and the NCCS “Cancer Survival Toolbox: An Audio Resource Program” that address medical and psychosocial issues, including those related to health insurance and employment.


NOTE: All individual and hospital names are fictitious.

SOURCE: Patricia Ganz, committee member, 2005.

Example of an End-of-Treatment Consultation Note: Prostate Cancer

Date of note: April 20, 2005

Name: John Doe Age: 65

Date of tissue diagnosis of cancer: October 21, 2001


Diagnosis: Prostate cancer

Stage of cancer: Clinical T1c

Pathologic findings: pT2cN0M0, Gleason 4+4, 2.3 cm


Initial treatment plan:

  • Surgery: Yes

  • Radiation therapy: None

  • Chemotherapy: None

Treatment received (specify dates, location, and providers):

Radical prostatectomy with nerve sparing on December 1, 2001, Eastside Medical Center, Dr. Roger Smith


Unusual or unexpected toxicities during treatment:

None


Expected short- and long-term effects of treatment:

Mild urinary leakage for 3 weeks, now dry

Sexual dysfunction for 3 months, now potent with occasional sildenafil


Late toxicity monitoring needed:

None

Page
159